Japan's Takeda has entered into a new manufacturing partnership with Hyderabad-based Biological E. Limited (BE) in India to boost production capacity for its dengue fever vaccine Qdenga. This collaboration aims to accelerate access to Qdenga and brings Takeda closer to its goal of producing 100 million doses of the vaccine...